Lifescan owner in good health
Published Date:
16 July 2008
HEALTHCARE giant Johnson & Johnson, owner of Inverness-based blood-sugar monitor maker Lifescan, revealed a 23 per cent rise in half-year profits yesterday.
Performance was boosted by sharply higher sales of medical devices and consumer products including its nonprescription allergy pill Zyrtec.
The New Jersey-based group reported profits of $6.93 billion, up 23 per cent on the same period last year. Revenue totalled $32.64bn, up 8 per cent.
The full article contains 77 words and appears in The Scotsman newspaper.
-
Last Updated:
15 July 2008 8:27 PM
-
Source:
The Scotsman
-
Location:
Edinburgh
